Logo Image
Is Less More? Antibiotic De-escalation in Hematopoietic Cell Transplants

Is Less More? Antibiotic De-escalation in Hematopoietic Cell Transplants

Featuring Diego R. Hijano, MD, MSc, Gabriela Marón, MD, MSc, Fareed Khawaja, MBBS

Watch Now
What Does Sevabertinib’s Expanded Approval Mean for HER2+ NSCLC?

What Does Sevabertinib’s Expanded Approval Mean for HER2+ NSCLC?

Featuring Xiuning Le, MD, PhD

Watch Now
How Oncologists Can Navigate Patient Requests for Medical Aid in Dying

How Oncologists Can Navigate Patient Requests for Medical Aid in Dying

Featuring Daniel C. McFarland, DO, Yesne Alici, MD

Watch Now
What Were the Key Hematologic Oncology Takeaways from SOHO 2026?

What Were the Key Hematologic Oncology Takeaways from SOHO 2026?

Featuring Jasmine Zain, MD, David Sallman, MD, Julie M. Vose, MD, MBA

Watch Now
Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC

Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC

Featuring Saum Ghodoussipour, MD

Watch Now
Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs

Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs

Featuring Surbhi Sidana, MD

Watch Now
Speaking With “One Voice” for World Radiotherapy Awareness Day

Speaking With “One Voice” for World Radiotherapy Awareness Day

Featuring Brandon Mancini, MD, MBA, FACRO , Sandra Turner, MBBS, PhD

Watch Now
How Mentorship and Peer Support Help Oncologists Avoid Burnout

How Mentorship and Peer Support Help Oncologists Avoid Burnout

Featuring Daniel C. McFarland, DO, Xiomara Rocha-Cadman, MD

Watch Now

Trending Videos

Sneak Peek: Practical CAR T Cell Use in Multiple Myeloma Care
1

Sneak Peek: Practical CAR T Cell Use in Multiple Myeloma Care

Commentary

What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?
2

What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?

Commentary

Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC
3

Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC

Commentary

What Were the Key Hematologic Oncology Takeaways from SOHO 2026?
4

What Were the Key Hematologic Oncology Takeaways from SOHO 2026?

Commentary

Suicide in Patients With Cancer: Identifying the Risk Factors
5

Suicide in Patients With Cancer: Identifying the Risk Factors

How Oncologists Can Navigate Patient Requests for Medical Aid in Dying
6

How Oncologists Can Navigate Patient Requests for Medical Aid in Dying

News

What Does Sevabertinib’s Expanded Approval Mean for HER2+ NSCLC?
7

What Does Sevabertinib’s Expanded Approval Mean for HER2+ NSCLC?

Commentary

Charting the Evolution of TKIs and Finding the Next Breakthrough in CML
8

Charting the Evolution of TKIs and Finding the Next Breakthrough in CML

Commentary

Exploring the Future of Radiopharmaceutical Therapy in Oncology
9

Exploring the Future of Radiopharmaceutical Therapy in Oncology

Commentary

Does Vitamin D Have a Role in Cancer Prevention?
10

Does Vitamin D Have a Role in Cancer Prevention?

Shorts

Paul Rubinstein, MD, highlighted the critical role multi-institutional networks play in advancing clinical research for rare cancer populations, particularly patients living with both HIV and cancer.
1:09
Advancing HIV-Associated Lymphoma Care Through Multi-Institutional Collaboration
3 days ago
by
Paul Rubinstein, MD
Zachary L. Bercu, MD, RPVI, FSIR, discussed how ergonomic strain from wearing lead in the angio suite, rather than radiation exposure itself, is the leading source of disability among interventional radiologists.
1:08
Can Robotic Systems Limit Ergonomic Injury for Interventional Radiologists?
5 days ago
by
Zachary L. Bercu, MD, RPVI, FSIR
Do Video Game Players Adapt Faster to Endovascular Robotics?
1:07
Do Video Game Players Adapt Faster to Endovascular Robotics?
6 days ago
by
Zachary L. Bercu, MD, RPVI, FSIR
How Does the PEDRA Portable Endovascular Robot Work?
1:21
How Does the PEDRA Portable Endovascular Robot Work?
7 days ago
by
Zachary L. Bercu, MD, RPVI, FSIR
Neeraj Agarwal, MD, FASCO, explained why delaying the onset of castration-resistant prostate cancer is crucial for preventing pain, fractures, and suffering in metastatic castration-sensitive disease.
1:18
TALAPRO-3 Data Show Striking 52% Reduction in CRPC Progression Risk
13 days ago
by
Neeraj Agarwal, MD
Neeraj Agarwal, MD, FASCO, explains why moving highly effective combination therapies upfront in metastatic castration-sensitive prostate cancer maximizes outcomes and prevents patient attrition.
1:15
Why Frontline Talazoparib/Enzalutamide Therapy Is Critical in Metastatic CSPC
13 days ago
by
Neeraj Agarwal, MD
Jason Konner, MD, highlighted the importance of expanding provider education to better guide post-journey patient conversations.
1:19
How Can Health Systems Foster Psychedelic Literacy in Oncology?
15 days ago
by
Jason Konner, MD
Elizabeth Thompson, MD, discussed why long-term toxicity plays a larger role in treatment decisions for pediatric patients with cancer compared with adults.
1:13
Why Long-Term Toxicity Weighs More Heavily in Pediatric Cancer Treatment Decisions
16 days ago
by
Elizabeth Thompson, MD
Elizabeth Thompson, MD, explained why smaller, retrospective studies often carry more influence in pediatric oncology than they would in adult oncology.
1:26
What Makes a Strong Pediatric Oncology Manuscript?
17 days ago
by
Elizabeth Thompson, MD
Faisal Mehmud, MD, MRCP, discussed the cardiovascular risks of androgen deprivation therapy for prostate cancer.
1:22
How Do GnRH Agents Impact Cardiovascular Risk in Prostate Cancer?
18 days ago
by
Faisal Mehmud, MD, MRCP

Expert Conversations

Around the Practice
Between the Lines
Face-Off
From All Angles
OncView
Training Academy
Frontline Forum

Shows & Podcasts

Oncology On the Go With ASTCT Talks
ONCOLOGY Decoded
RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO
Oncology-on-the-Go with Daniel C. McFarland, DO
The AI Oncology Revolution
Double Blind

News & Analysis

Videos